Marco Donia
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Marco Donia
May 12, 2024, 17:41 |
Insight
Marco Donia: Circadian rhythm, tumor infiltration of CD8+ T cells, and cancer immunotherapy
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: “Circadian…
May 6, 2024, 07:29 |
Insight
Center for Cancer Immune Therapy - Molecular patterns of resistance to immune checkpoint blockade in melanoma
Center for Cancer Immune Therapy shared on LinkedIn: "Molecular patterns of resistance to immune checkpoint…
May 2, 2024, 13:23 |
Insight
Marco Donia: Welcoming the Era of Gene Editing in Medicine
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "Autologous…
Apr 20, 2024, 07:47 |
Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 11, 2024, 15:57 |
Insight
Marco Donia: Therapeutic Cancer Vaccines - update in Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 9, 2024, 05:22 |
Blog
Marco Donia: Must Read: 50 years of Advances in Cancer Research
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Mar 22, 2024, 18:47 |
Blog
Alessandra Fontecedro: The first Swiss Oncology Summer School
Alessandra Fontecedro, Head Medical Oncology at HFR Fribourg Hospital, shared on LinkedIn: "To medical students:…
Mar 1, 2024, 17:25 |
Insight
Marco Donia: The 'Influencers' of Cancer Immunotherapy do not affect immunotherapy outcomes
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn: "The…
Feb 19, 2024, 17:52 |
Insight
Marco Donia: Pan-cancer proteogenomics characterization of tumor immunity
Marco Donia, Associate Professor at National Center for Cancer Immune Therapy, Denmark, shared on LinkedIn: ''Pan-cancer…
Feb 10, 2024, 23:33 |
Insight
Bettina Ryll: Got to kind of love the authors
Bettina Ryll, Founder of MPNEurope, shared a post by Marco Donia, Associate Professor at National Center for…
1
2
All:
17
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube